NOVARTIS AG financial data

Symbol
NVS on NYSE, NVSEF on OTC
Location
Basel, Switzerland
Fiscal year end
31 December
Latest financial report
20-F - Q4 2025 - 04 Feb 2026

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,908,151,679 shares -3.4%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense $2,727,000,000 USD 15%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill $25,567,000,000 USD 3.3%
Assets $110,949,000,000 USD 8.5%
Liabilities $64,400,000,000 USD 11%

Popular Metrics

Label TTM Value / Value Unit Change %
Interest Expense $289,000,000 USD 17%